These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33293179)

  • 1. COVID-19: Broadening the horizons of U.S. harm reduction practices through managed alcohol programs.
    Mehtani NJ; Ristau JT; Eveland J
    J Subst Abuse Treat; 2021 May; 124():108225. PubMed ID: 33293179
    [No Abstract]   [Full Text] [Related]  

  • 2. Addressing a rapidly changing service landscape during the COVID-19 pandemic: Creation of the Oregon substance use disorder resource collaborative.
    Lockard RA; Priest KC; Brown PCM; Graveson A; Englander H
    J Subst Abuse Treat; 2021 May; 124():108244. PubMed ID: 33339632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful implementation of managed alcohol programs in the San Francisco Bay Area during the COVID-19 crisis.
    Ristau J; Mehtani N; Gomez S; Nance M; Keller D; Surlyn C; Eveland J; Smith-Bernardin S
    Subst Abus; 2021; 42(2):140-147. PubMed ID: 33848451
    [No Abstract]   [Full Text] [Related]  

  • 4. Addiction Medicine After COVID-19: The Imperative of a Trained Workforce.
    Wu JH; Rich JD; Adashi EY
    Am J Prev Med; 2021 May; 60(5):729-731. PubMed ID: 33581936
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary: Harm reduction, managed alcohol programs and doing the right thing.
    Gaetz S
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S195-S196. PubMed ID: 29737613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managed alcohol programs: Reducing social and injury harm, but what about long-term health harm?
    Room R
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S197-S198. PubMed ID: 29498119
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
    Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
    Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis.
    Englander H; Dobbertin K; Lind BK; Nicolaidis C; Graven P; Dorfman C; Korthuis PT
    J Gen Intern Med; 2019 Dec; 34(12):2796-2803. PubMed ID: 31410816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital.
    Hyshka E; Morris H; Anderson-Baron J; Nixon L; Dong K; Salvalaggio G
    Drug Alcohol Depend; 2019 Nov; 204():107523. PubMed ID: 31541875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA).
    Testino G; Vignoli T; Patussi V; Allosio P; Amendola MF; Aricò S; Baselice A; Balbinot P; Campanile V; Fanucchi T; Macciò L; Meneguzzi C; Mioni D; Parisi M; Renzetti D; Rossin R; Gandin C; Bottaro LC; Caio G; Lungaro L; Zoli G; Scafato E; Caputo F
    Addict Biol; 2022 Jan; 27(1):e13090. PubMed ID: 34532923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Not Available].
    Papas A
    Rev Infirm; 2018 Jan; 67(237):15. PubMed ID: 29331184
    [No Abstract]   [Full Text] [Related]  

  • 12. [Day clinic, a gateway towards risk reduction].
    Ben Nifla V; Celli P; Samba H; Vincent C
    Rev Infirm; 2018 Jan; 67(237):28-30. PubMed ID: 29331189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managed alcohol programs: Is it time for a more radical approach to reduce harms for people experiencing homelessness and alcohol use disorders?
    Stockwell T; Pauly BB
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S129-S131. PubMed ID: 29473239
    [No Abstract]   [Full Text] [Related]  

  • 14. Harm Reduction for Women in Treatment for Alcohol Use Problems: Exploring the Impact of Dominant Addiction Discourse.
    Brown C; Stewart SH
    Qual Health Res; 2021 Jan; 31(1):54-69. PubMed ID: 32985360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grayken lessons: between a rock and a hard place? A 37-year-old man with acute liver injury while enrolled in a managed alcohol program for severe alcohol use disorder.
    Brothers TD; Walley AY; Rivers-Bowerman H; McLeod M; Genge L
    Addict Sci Clin Pract; 2023 Mar; 18(1):14. PubMed ID: 36879279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical guideline highlights for the hospitalist: 2020 American Society of Addiction Medicine clinical practice guideline on alcohol withdrawal management.
    Ganatra RB; Breu AC; Ronan MV
    J Hosp Med; 2022 Jan; 17(1):47-49. PubMed ID: 34910619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addiction medicine ethics: relapse, no lapse and the struggle to treat addicts like everyone else.
    Douglas C
    Intern Med J; 2017 Oct; 47(10):1121-1123. PubMed ID: 28994253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges of treatment of acutely ill patients enrolled in a managed alcohol program.
    Hill M; Vipler S; Sutherland C; Nolan S
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1(Suppl 1):S143-S144. PubMed ID: 28868652
    [No Abstract]   [Full Text] [Related]  

  • 19. Operating principles from Ottawa's managed alcohol program.
    Muckle J; Muckle W; Turnbull J
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S140-S142. PubMed ID: 29737616
    [No Abstract]   [Full Text] [Related]  

  • 20. On the outside looking in: Finding a place for managed alcohol programs in the harm reduction movement.
    Ivsins A; Pauly B; Brown M; Evans J; Gray E; Schiff R; Krysowaty B; Vallance K; Stockwell T
    Int J Drug Policy; 2019 May; 67():58-62. PubMed ID: 30959410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.